• Citer

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.

par Awada, Ahmad ;Gil, Thierry ;Sales, Francois;Dubuisson, Michel Raymond ;Vereecken, P;Klastersky, Jean ;Moerman, Carine;de Valeriola, Dominique ;Piccart-Gebhart, Martine
Référence Anti-cancer drugs, 15, 5, page (499-502)
Publication Publié, 2004-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.
Auteur:	Awada, Ahmad; Gil, Thierry; Sales, Francois; Dubuisson, Michel Raymond; Vereecken, P; Klastersky, Jean; Moerman, Carine; de Valeriola, Dominique; Piccart-Gebhart, Martine
Informations sur la publication:	Anti-cancer drugs, 15, 5, page (499-502)
Statut de publication:	Publié, 2004-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Dacarbazine -- administration & dosage
	Dacarbazine -- analogs & derivatives
	Doxorubicin -- administration & dosage
	Drug Administration Schedule
	Female
	Humans
	Infusions, Intravenous
	Liposomes
	Male
	Maximum Tolerated Dose
	Middle Aged
	Neoplasms -- drug therapy
	Neutropenia -- chemically induced
	Stomatitis -- chemically induced
	Treatment Outcome
Note générale:	Clinical Trial
	Clinical Trial, Phase I
	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0959-4973
	info:pii/00001813-200406000-00012
	info:pmid/15166625